EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Noninvasive prediction of CCL2 expression level in high‐grade glioma patients

Qingqing Zhou, Yamei Wang, Qing Zhang, XiaoMing Wei, Yuan Yao, Liang Xia iD

Cancer Medicine · 2024

DOI: 10.1002/cam4.70016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Qingqing Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First Affiliated Hospital of Yangtze University, Jingzhou First People's Hospital, Jingzhou, People's Republic of Chi…. Hauptthemen laut MEDLINE: Brain Neoplasms, Chemokine CCL2, Glioma. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Zhejiang Province, Zhejiang Medical Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Gliomas are recognized as the most frequent type of malignancies in the central nervous system, and efficacious prognostic indicators are essential to treat patients with gliomas and improve their clinical outcomes. The chemokine (C‐C motif) ligand 2 (CCL2) is a promising predictor for glioma malignancy and progression. However, at present, the methods to evaluate CCL2 expression level are invasive and operator‐dependent.

Objective

It was expected to noninvasively predict CCL2 expression levels in malignant glioma tissues by magnetic resonance imaging (MRI)‐based radiomics and assess the association between the developed radiomics model and prognostic indicators and related genes.

Methods

MRI‐based radiomics was used to predict CCL2 expression level using data obtained from The Cancer Imaging Archive (TCIA) and The Cancer Genome Atlas (TCGA) databases. A support vector machine (SVM)‐based radiomics model and a logistic regression (LR)‐based radiomics model were used to predict the radiomics score, and its correlation with CCL2 expression level was analyzed.

Results

The results revealed that there was an association between CCL2 expression level and the overall survival of cases with gliomas, and bioinformatics correlation analysis showed that CCL2 expression level was highly correlated with disease‐related pathways, such as mTOR signaling pathway, cGMP‐PKG signaling pathway, and MAPK signaling pathway. Both SVM‐ and LR‐based radiomics data robustly predicted CCL2 expression level, and radiomics scores could also be used to predict the overall survival of patients. Moreover, the high/low radiomics scores were highly correlated with the known glioma‐related genes, including CD70, CD27, and PDCD1.

Conclusion

An MRI‐based radiomics model was successfully developed, and its clinical benefits were confirmed, including the prediction of CCL2 expression level and patients' prognosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain NeoplasmsChemokine CCL2GliomaAdultAgedFemaleHumansMaleMiddle AgedBiomarkers, TumorGene Expression Regulation, NeoplasticMagnetic Resonance ImagingNeoplasm GradingPrognosisSupport Vector Machine

Stichwörter der Autor:innen

CCL2 expression levelMRI‐based radiomicsgliomasmachine learningnoninvasive prediction

Substanzen

Biomarkers, TumorCCL2 protein, humanChemokine CCL2

Autor:innen und Institutionen

  • Department of Neurosurgery, The First Affiliated Hospital of Yangtze University, Jingzhou First People's Hospital, Jingzhou, People's Republic of China.
  • Department of Neurology, The First Affiliated Hospital of Yangtze University, Jingzhou First People's Hospital, Jingzhou, People's Republic of China.
  • Department of Radiology, The First Affiliated Hospital of Yangtze University, Jingzhou First People's Hospital, Jingzhou, People's Republic of China.
  • Department of Neurosurgery, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, People's…

ORCID-Profile: Liang Xia

Förderung

  • Natural Science Foundation of Zhejiang Province
  • Zhejiang Medical Science and Technology Project

Zitieren

APA

Zhou, Q., Wang, Y., Zhang, Q., Wei, X., Yao, Y., & Xia, L. (2024). Noninvasive prediction of CCL2 expression level in high‐grade glioma patients. Cancer Medicine. https://doi.org/10.1002/cam4.70016

Vancouver

Zhou Q, Wang Y, Zhang Q, Wei X, Yao Y, Xia L. Noninvasive prediction of CCL2 expression level in high‐grade glioma patients. Cancer Medicine. 2024. doi:10.1002/cam4.70016

BibTeX
@article{Zhou2024,
  author = {Zhou, Qingqing and Wang, Yamei and Zhang, Qing and Wei, XiaoMing and Yao, Yuan and Xia, Liang},
  title = {Noninvasive prediction of CCL2 expression level in high‐grade glioma patients},
  journal = {Cancer Medicine},
  year = {2024},
  doi = {10.1002/cam4.70016}
}
Kostenlos starten →